Skip to main content
2024 State-of-the Art Clinical Symposium Main banner
Final Program


Schedule at a Glance
Back

Lung Disease in Scleroderma

Sunday, April 14, 2024
9:10 AM – 9:55 AM Central Time

    Moderator(s)

  • Kevin Byram, MD

    Vanderbilt University Medical Center
    Nashville, TN, United States

    Disclosure(s): Hemoshear Therapeutics: Consultant (Terminated, August 10, 2023)

    • Speaker(s)

  • Dinesh Khanna, MD, MSc

    University of Michigan
    Ann Arbor, MI, United States

    Disclosure(s): Chemomab: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Zuro Bio: Consultant (Ongoing)

The session is will discuss the risk factors for ILD in systemic sclerosis (SSc) and present recent guidelines on screening and management of SSc-ILD.

Learning Objectives:

  • Discuss the risk factors for ILD in systemic sclerosis (SSc).
  • Discuss recent guidelines on screening and management of SSc-ILD.

Presentations:

  • 9:10 AM – 9:40 AM Central Time
    Lung Disease in Scleroderma

    Speaker: Dinesh Khanna, MD, MSc – University of Michigan

  • 9:40 AM – 9:55 AM Central Time
    Q&A

    Q&A Moderator: Kevin Byram, MD – Vanderbilt University Medical Center

    Q&A Presenter: Dinesh Khanna, MD, MSc – University of Michigan